McKesson Corp (MCK)

162.36
NYSE : Services
Prev Close 162.36
Day Low/High 0.00 / 0.00
52 Wk Low/High 114.53 / 199.43
Avg Volume 1.77M
Exchange NYSE
Shares Outstanding 210.90M
Market Cap 34.00B
EPS 22.90
P/E Ratio 6.93
Div & Yield 1.12 (0.70%)

Latest News

McKesson Upgraded at JPMorgan

McKesson Upgraded at JPMorgan

The firm's analyst believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted.

Analysts' Actions -- Cloudera, Carvana, Domino's, McKesson and More

Analysts' Actions -- Cloudera, Carvana, Domino's, McKesson and More

Here are Tuesday's top research calls, including new coverage of recent IPOs Cloudera and Carvana, as well as new analyst coverage of Domino's Pizza and an upgrade of McKesson.

These Stocks Are Changing Direction

These Stocks Are Changing Direction

Finding bullish and bearish reversals in the market.

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Ahead of Fed's June meeting, investors will need to start paying close attention to Fed officials and economic data.

Rebound Reality; Best Tech Story: Jim Cramer's Best Blog

Rebound Reality; Best Tech Story: Jim Cramer's Best Blog

Jim Cramer discusses the rebound and also mentions the best tech story that no one knows about.

Cramer: The Rebound is Real. Now What?

Cramer: The Rebound is Real. Now What?

With stocks rebounding, investors face a tough choice.

McKesson Shares Jump After Fourth Quarter Beat

McKesson Shares Jump After Fourth Quarter Beat

The drug distributor reported better-than-expected adjusted EPS for the fourth quarter of fiscal 2017.

McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results

McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2017, were $48.

Market Recon: Corporate America Is Fundamentally Sound

Market Recon: Corporate America Is Fundamentally Sound

Of firms that reported, 75% beat expectations for earnings per share, while 64% beat revenue projections.

Eyes Are on McKesson's Guidance

Eyes Are on McKesson's Guidance

The drug distributor is scheduled to report quarterly results after the market close on Thursday.

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Concert must submit toxicology data to the FDA before proceeding with Phase 2 trials.

Analysts' Actions -- AMD, Clovis, ConocoPhillips, Disney, Transocean and More

Analysts' Actions -- AMD, Clovis, ConocoPhillips, Disney, Transocean and More

Here are Wednesday's top research calls, including new coverage of Advanced Micro Devices and Transocean, upgrades for Clovis Oncology and ConocoPhillips, and a downgrade for Disney.

Here Are Some of Congress' Favorite Stocks

Here Are Some of Congress' Favorite Stocks

While hard at work in Washington, a handful of members of Congress have also been busy trading stocks.

McKesson: Bears Still Have the Upper Hand

McKesson: Bears Still Have the Upper Hand

MCK has rolled over again and prices are pointed lower

McKesson Corporation Fiscal 2017 Fourth Quarter Conference Call Scheduled For May 18, 2017

McKesson Corporation (NYSE:MCK) will release financial results for its fourth fiscal quarter ended March 31, 2017 on Thursday, May 18, 2017, following the market close at approximately 4:00 PM Eastern Time (1:00 PM Pacific...

McCormick Stock Higher on JPMorgan Upgrade

McCormick Stock Higher on JPMorgan Upgrade

JPMorgan has a 'neutral' rating on McCormick stock.

McKesson Completes Acquisition Of CoverMyMeds

McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of CoverMyMeds LLC.

McKesson Provides Financial Update To Reflect Creation Of A New Healthcare Information Technology Company

McKesson Corporation (NYSE:MCK), a leading global healthcare services and information technology company, and Change Healthcare Holdings, Inc.

McKesson And Change Healthcare Complete The Creation Of New Healthcare Information Technology Company

McKesson Corporation (NYSE:MCK), a leading global healthcare services and information technology company, and Change Healthcare Holdings, Inc.

University Of Wisconsin Puts FHIR To Work

A research project led by Dr. Richard Bruce of the University of Wisconsin-Madison is now underway to use the latest iteration of the Fast Healthcare Interoperability Resources (FHIR ®) standard to improve radiology...

Here's Why AmerisourceBergen Is Up 16% This Year

Here's Why AmerisourceBergen Is Up 16% This Year

The pharmaceutical distributor is finally turning around.

McKesson Offers Healthy Upside Potential

McKesson Offers Healthy Upside Potential

You need to see where the health services giant normally trades to appreciate how undervalued it is.

Wake County EMS Selects McKesson

Wake County EMS, the emergency medical service agency serving North Carolina's second-most populous county and the cities of Raleigh and Cary, has selected McKesson Business Performance Services (McKesson) for...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of McKesson Corporation

Levi & Korsinsky announces it has commenced an investigation of McKesson Corporation (NYSE:MCK) concerning possible breaches of fiduciary duty by the board of directors of the company.

Oregon Advanced Imaging Selects McKesson For Revenue Cycle Management

Medford, Oregon-based Oregon Advanced Imaging has chosen McKesson Business Performance Services (McKesson) for help in improving charge capture, accelerating accounts receivable and reducing bad debt.

Learn More About How ACO Partner Can Help Providers Transition To Value-based Care

ACO Partner, a newly formed joint venture designed to help strengthen clinical and financial outcomes for patients, providers and payers, is continuing to gain momentum and market share following its launch in...

Buy Retail, Pharma, Health-Care on Dips

Buy Retail, Pharma, Health-Care on Dips

Demographics will continue to favor health-care and pharmaceutical companies.